Quality of Life Among Individuals with HIV Starting Antiretroviral Therapy in Diverse Resource-Limited Areas of the World
- 16 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in AIDS and Behavior
- Vol. 16 (2), 266-277
- https://doi.org/10.1007/s10461-011-9947-5
Abstract
As Antiretroviral Therapy (ART) is scaled up in low- and middle-income countries, it is important to understand Quality of Life (QOL) correlates including disease severity and person characteristics and to determine the extent of between-country differences among those with HIV. QOL and medical data were collected from 1,563 of the 1,571 participants at entry into a randomized clinical trial of ART conducted in the U.S. (n = 203) and 8 resource-limited countries (n = 1,360) in the Caribbean, South America, Asia, and Africa. Participants were interviewed prior to initiation of ART using a modified version of the ACTG SF-21, a health-related QOL measure including 8 subscales: general health perception, physical functioning, role functioning, social functioning, cognitive functioning, pain, mental health, and energy/fatigue. Other measures included demographics, CD4+ lymphocyte count, plasma HIV-1 RNA viral load. Higher quality of life in each of the 8 QOL subscales was associated with higher CD4+ lymphocyte category. General health perception, physical functioning, role functioning, and energy/fatigue varied by plasma HIV-1 RNA viral load categories. Each QOL subscale included significant variation by country. Only the social functioning subscale varied by sex, with men having greater impairments than women, and only the physical functioning subscale varied by age category. This was the first large-scale international ART trial to conduct a standardized assessment of QOL in diverse international settings, thus demonstrating that implementation of the behavioral assessment was feasible. QOL indicators at study entry varied with disease severity, demographics, and country. The relationship of these measures to treatment outcomes can and should be examined in clinical trials of ART in resource-limited settings using similar methodologies.Keywords
This publication has 27 references indexed in Scilit:
- Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adultsEmergencias, 2010
- Racial Differences in Virologic Failure Associated With Adherence and Quality of Life on Efavirenz-Containing Regimens for Initial HIV TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Creating a Crosswalk to Estimate AIDS Clinical Trials Group Quality of Life Scores in a Nationally Representative Sample of Persons in Care for HIV in the United StatesHIV Research & Clinical Practice, 2005
- The Use of Highly Active Antiretroviral Therapy (HAART) in Patients With Advanced HIV Infection: Impact on Medical, Palliative Care, and Quality of Life OutcomesJournal of Pain and Symptom Management, 2001
- Physical and Role Functioning Among Persons With HIVMedical Care, 2000
- Quality of life outcomes of combination zidovudine–didanosine–nevirapine and zidovudine–didanosine for antiretroviral-naive advanced HIV-infected patientsAIDS, 2000
- Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapyAIDS, 2000
- The MOS Short-form General Health SurveyMedical Care, 1988
- The structure of psychological distress and well-being in general populations.Journal of Consulting and Clinical Psychology, 1983
- The structure of psychological distress and well-being in general populations.Journal of Consulting and Clinical Psychology, 1983